Graviton BioScience Corp

Graviton BioScience is a New York-based clinical-stage biotechnology company, founded in 2020, that develops selective ROCK2 inhibitors for fibrotic, autoimmune and central nervous system diseases. Its lead candidate, the oral ROCK2 inhibitor GV101, received FDA Fast Track designation for Friedreich's ataxia in November 2026, and the company maintains partnerships with Sanofi, Ovid Therapeutics and Sino Biopharmaceutical as well as the CinRock Pharma joint venture with CinRx Pharma. Prior backers include Pontifax Venture Capital, Enavate Sciences and Sanofi Capital.

  • Series B
  • Biotechnology
  • Clinical Trials
  • Healthtech
  • Pharmaceuticals
  • Healthcare & Life Sciences

1

Round

1

Industry

5

Tags

Nov 16, 2026

Latest raise

Funding activity · 1 round

Raise timeline

  1. Nov 16, 2026

    $5M

    Series B

    Article coming soon.

Pricing

Research Graviton BioScience Corp — then scale the playbook

Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.

Enterprise

Custom pricing for unlimited scale. Let's talk.

Contact sales

Growth plan

For individuals and small teams getting started with AI buyer intelligence.

$149

/month

Features

  • Access to core AI adoption signals
  • 3–5 curated slices per week
  • 30–60 companies / week
  • AI Adoption Score
  • Deal-ready insights (why + pitch angle)
  • Basic filters (recency, slice, score)
  • CSV export
Most popular

Pro plan

For outbound teams and agencies that need more coverage and faster signal cadence.

$249

/month

Features

  • Everything in Growth, plus:
  • Full access to all slices
  • 60–120 companies / week
  • Higher-frequency signal updates
  • Priority / early signals (before Growth)
  • Advanced filters (industry, size, use case)
  • Deeper company insights
  • Faster export + bulk workflows

Act on this raise

See if Graviton BioScience Corp is moving on AI

Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.

© 2026 VeilStrat. All rights reserved.All systems operational